2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $110M | $138M | $163M | $166M | $155M |
Cost of Revenue | $61M | $77M | $93M | $92M | $83M |
Gross Profit | $50M | $61M | $70M | $75M | $72M |
Gross Profit % | 45% | 44% | 43% | 45% | 46% |
R&D Expenses | $0 | $0 | $0 | $0 | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | -$6.1M | -$88M | -$48M | -$21M | -$24M |
Dep. & Amort. | $932K | $997K | $1.3M | $1.6M | $1.3M |
Def. Tax | $2K | -$4K | $0 | $0 | $0 |
Stock Comp. | $7.9M | $78M | $27M | $8.3M | $5M |
Chg. in WC | -$6M | -$9.5M | -$2.1M | $0 | $15M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $15M | $43M | $47M | $32M | $31M |
ST Investments | $0 | $30M | $0 | $0 | $0 |
Cash & ST Inv. | $15M | $73M | $47M | $32M | $31M |
Receivables | $6.9M | $9M | $11M | $11M | $11M |
Inventory | $21M | $32M | $28M | $35M | $19M |
ZVIA reported a 4.4% increase in Q4 2024 net sales to $39.5 million, driven by an 11.6% increase in cases sold, with gross margins reaching a record high of 49.2%.
The company achieved full-year 2024 net sales of $155.1 million, a 6.8% decline due to lost distribution and increased promotional spend, but improved gross margins to 46.4% and reduced adjusted EBITDA loss to $15.2 million.
For fiscal 2025, ZVIA expects net sales between $158 million and $163 million, with adjusted EBITDA loss projected at $8 million to $11 million, and gross margins in the high 40% range.
The company plans to increase marketing investments to low double digits as a percentage of sales, focusing on awareness and trial, while leveraging successful campaigns like "Break from the Artificial."
ZVIA remains committed to achieving positive adjusted EBITDA by 2026, supported by cost-saving initiatives, expanded distribution (e.g., Walmart and Albertsons), and product innovation such as new flavors and variety packs.